Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The major myelin-resident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide.
The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis.
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy.
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
Coexistence of Guillain-Barré syndrome and Behçet's disease.
Primary Sjögren's syndrome related optic neuritis.
Acute paraplegia caused by Schistosoma mansoni.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.
Employment among Patients with Multiple Sclerosis-A Population Study.
Epstein-Barr virus in multiple sclerosis.
C-11Utility of the Ten Item Personality Inventory (TIPI) in Multiple Sclerosis (MS): What Can 10 Items Tell Us?
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis.
Erythropoietin: new directions for the nervous system.
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.]
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Dermatoglyphic features in patients with multiple sclerosis.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Linking synaptopathy and gray matter damage in multiple sclerosis.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.

Pages